Journal archive · by topic
Non-surgical rhinoplasty
Injecting hyaluronic acid into the nose takes fifteen minutes, satisfies almost everyone who has it, lasts eight to fourteen months, and carries one risk that no amount of satisfaction offsets: filler entering an artery, which in 22 published cases took the patient's sight and gave it back to only 27% of them. Everything in this literature is a trade between that risk and the fact that, for the right complaint, a syringe does what an operation would otherwise have to.
Where these 88 papers were published
- 29Aesthetic Plastic SurgeryAesthetic Plast Surg
- 14Plastic and Reconstructive SurgeryPlast Reconstr Surg
- 10Facial Plastic SurgeryFacial Plast Surg
- 10Facial Plastic Surgery and Aesthetic MedicineFacial Plast Surg Aesthet Med
- 8Plastic and Reconstructive Surgery Global OpenPlast Reconstr Surg Glob Open
- 7Facial Plastic Surgery Clinics of North AmericaFacial Plast Surg Clin North Am
- 6Aesthetic Surgery JournalAesthet Surg J
- 3Clinics in Plastic SurgeryClin Plast Surg
- 1JAMA Facial Plastic SurgeryJAMA Facial Plast Surg
11 further papers on this topic came in through the history rather than the archive query: Beleznay K 2015, Liew S 2016, Signorini M 2016, Schelke LW 2017 and 7 more. They are counted on the landmark papers, not here.
What repeats
Six findings reported by independent groups in different countries. Each card carries the papers it rests on.
Satisfaction is near-universal and short-lived
Eight studies and 674 patients: 100% satisfied immediately, 98.2% in the following weeks, 84.7% at three months and 96.4% of the smaller group still followed at a year, with the effect lasting eight to fourteen months. Across 23 studies and 1,600 patients, nearly 95% were satisfied; across 30 studies and 9,657 patients, 99.08%. Measured properly with FACE-Q in 83 prospective patients, satisfaction and psychological function rose immediately and were only slightly lower at six months as the filler resorbed. Nobody in this literature reports an unhappy cohort.
Rests on: Radulesco et al., 674 patients · Williams et al., 1,600 patients · Song et al., 9,657 patients · Lombardo et al., FACE-Q at six months.
The catastrophic complication is vascular, immediate and mostly permanent
Twenty-two published cases of vision loss after nasal filler: mean age 33.4, 90.9% women, hyaluronic acid in half, and the injection site the nasal dorsum in 57%. Vision loss was immediate in 82% of cases, and only 27% recovered fully, taking an average of 5.3 months, despite hyaluronidase, steroids and antibiotics. In the largest pooled series, arterial occlusion of any kind occurred in 0.27% of 9,657 patients. That is a small number attached to an outcome nobody accepts.
Rests on: Pistone et al., systematic review of vision loss · Song et al. · Caranti et al., complications reviewed.
Everything else that goes wrong is common and minor
Swelling and redness affect roughly half of patients in the largest single-clinician series and 27.95% in the pooled data; the rest of the list is asymmetry, injection-site reactions, hypersensitivity, nodules, granulomas, a bluish tint from filler placed too superficially, and infection. In 5,000 consecutive treatments by one clinician, there were two infections and three cases of localised skin necrosis. In 2,048 pooled post-surgical patients the major complication rate was low but skin necrosis was specifically raised.
Rests on: Harb and Brewster, 5,000 treatments · Song et al. · Santamaría-Gadea et al., filler after rhinoplasty.
Technique is where the risk is managed, and the field has converged on how
Three things recur across every protocol: inject deep and in the midline where the vessels are not, use small boluses, and prefer a blunt cannula through a single entry point to a needle. The published grid, four-point and sequential protocols all encode the same anatomy. In 528 East Asian patients injected by cannula in a fixed sequence, there were no vascular complications at all; in 400 patients treated by a four-point technique the same principle is stated as boluses of 0.05 mL or less in the midline at depth.
Rests on: Radulesco et al., a single-entry cannula procedure · Ye et al., 528 patients, cannula, sequential · Silikovich and Kroumpouzos, the four-point technique · Bertossi et al., the nasal grid · Rohrich et al., five principles and five steps.
Filler in a nose that has already been operated on is a different risk
Every patient in one skin-necrosis series had had a rhinoplasty more than three years earlier, and the systematic review of filler after rhinoplasty (20 articles, 2,048 patients) records an increased risk of skin necrosis alongside high satisfaction. Previous surgery moves and scars the blood supply, so the safe planes are no longer where the anatomy books put them. It is also the commonest reason to inject at all in some practices: bridge collapse or asymmetry (49.0%), an under-projected tip (44.0%) and surface irregularity or scarring (35.4%) across 2,088 post-surgical cases.
Rests on: Robati et al., necrosis after previous rhinoplasty · Santamaría-Gadea et al. · Harb and Abdul-Razzak, 2,088 non-surgical revisions · Valente and Zanella, 1,122 secondary cases.
Filler is not inert, and what it leaves behind becomes a surgical problem
In a rabbit model, hyaluronic acid filler injected against lateral cartilage produced chondrocyte nucleus loss, fibrosis and giant-cell reaction at 90 days without thinning the cartilage. In people, long-standing or migrated filler produces fibrosis, granulomas, skin irregularity and the distorted "Avatar nose" that now has its own surgical algorithm: ultrasound to find residual filler, hyaluronidase to dissolve what will dissolve, then open revision with cartilage. East Asian series describe the same salvage: remove the injected material completely, then rebuild with rib.
Rests on: Gürlek et al., histopathology in a rabbit model · Wong and D'Souza, surgical management of filler complications · Ye et al., revision after non-surgical filler.
By use
What non-surgical rhinoplasty is actually used for, and how well each use is evidenced.
The dorsal hump
The commonest indication, 44% of 5,000 consecutive treatments. Filler does not remove a hump; it fills the dip above and below it so the profile reads straight. It works for a small hump on a straight nose and it makes a large nose larger.
Key papers: Harb and Brewster · Mortada et al., 3,928 patients reviewed.
The tip and the columella
Rotation and projection from small volumes: a four-point diamond injection of a mean 0.12 mL rated excellent in 90.65% of 107 patients at six months; a columella-focused technique in 140 patients; the tip the most commonly injected site across 13 of 23 studies. This is the use with the least tissue to work with and the most reported technique variation.
Key papers: Betti et al., diamond injection technique · Scarano et al., cross-linked hyaluronic acid at the tip · Mortada et al..
The radix and the nasofrontal angle
Filling the root of the nose changes the perceived length and the angle to the forehead. Measured by three-dimensional scanning in 426 patients, a sequential tip-dorsum-glabella protocol moved nasal length 2.62 mm, tip projection 3.69 mm, the nasolabial angle 5.7 degrees and the nasofrontal angle 9.4 degrees.
Key paper: Ye et al..
After a rhinoplasty
The largest use by patient count in the published series: 2,088 and 1,122 post-surgical cases in two practices, treating bridge collapse, an under-projected tip, and irregularity or scarring, at a mean of about 0.5 mL, with complication rates of 2.8% in one and low major-complication rates in the other. It is also the use with the highest necrosis risk.
Key papers: Harb and Abdul-Razzak · Valente and Zanella · Santamaría-Gadea et al..
The deviated nose, and what filler cannot do
A modified four-point technique in 80 patients is the only protocol on file aimed at the appearance of septal deviation, and it is explicitly limited to mild-to-moderate caudal deviation. Filler cannot straighten a septum, cannot open an airway, and cannot make a nose smaller. Where the structure has collapsed, the saddle nose, filler has one documented preoperative role: expanding contracted skin before a surgical reconstruction beneath it.
Key papers: Silikovich and Kroumpouzos, modified technique for septal deviation · Battista et al., filler-assisted skin expansion.
Patients of African descent, and other groups
487 patients of African descent treated for lack of bridge definition (63.9%), excess alar width (61.6%) and a bulbous tip (61.6%), at a median 0.6 mL at the first visit, with no infection, occlusion or necrosis. 528 East Asian patients treated by a cannula protocol with no vascular complications. These are the two largest group-specific series on file, and both report large gains at small volumes.
Key papers: Harb and Abdul-Razzak, 487 patients of African descent · Ye et al..
Who is injecting
In 59 patients treated by 53 injectors of varying experience, satisfaction, volume used and perceived duration did not differ by the injector's experience level: a finding that cuts both ways, since the outcome measured was appearance rather than safety, and the catastrophic complications in this literature are rare enough that a 59-patient study could not detect a difference in them.
Key paper: Germani et al., outcomes across injectors.
The terms, defined
Every term the papers above use to mean something specific, in plain language.
- Non-surgical rhinoplasty (liquid rhinoplasty, rhinofiller): reshaping the nose with injectable filler rather than surgery. It adds volume; it cannot remove it. [32590640, 36728574]
- Hyaluronic acid (HA): the filler used in 67% to 97% of cases across the reviews. Reversible with hyaluronidase, which is why it is preferred in the nose. [38862661, 37217605]
- Calcium hydroxyapatite (CaHA): a stiffer, non-reversible filler used in about 1% to 12% of cases depending on the series; the lack of an antidote is the argument against it in the nose. [38862661, 32590640]
- G prime (G′): how stiff a filler is under stress. High-G′ products hold a shape and are used at the columella and radix; intermediate-G′ products are used where softness matters. [32628267, 39060796]
- Rheology: the study of how a filler flows and deforms: viscosity, elasticity and cohesivity, the properties that decide where a product belongs. [37783865]
- Vascular occlusion: filler entering or compressing an artery, causing tissue ischaemia. The mechanism behind necrosis, blindness and stroke. [42660550, 38862661]
- Hyaluronidase: the enzyme that dissolves hyaluronic acid, kept at hand for emergencies. It did not restore vision in most of the published cases. [42660550, 41412200]
- Cannula against needle: a blunt cannula through one entry point is less likely to enter a vessel than a sharp needle; the technique papers converge on it. [35511074, 42443422]
- Nasal grid and four-point protocols: published maps of where to inject, how much, and in what order, so the procedure is reproducible rather than improvised. [30531619, 39060796]
- Tyndall effect: the bluish look of filler placed too superficially. [39747417]
- Granuloma and biofilm: a chronic inflammatory nodule and a bacterial community on injected material; both present late. [39747417]
- "Avatar nose": the widened, distorted appearance of a nose carrying repeated or migrated filler; now a named surgical indication. [41412200]
- GAIS (Global Aesthetic Improvement Scale): the five-point rating of change against a baseline photograph used in most of these studies. [37267216, 41813985]
- FACE-Q: the validated appearance and psychological well-being instrument; the most rigorous outcome measure used in this literature. [39747421, 42443422]
The papers this rests on
The 40 papers everything above was written from. Every one links to its abstract, its authors and its DOI.
- ASJ Vision Loss Following Nonsurgical Rhinoplasty Injections: Systematic Review of Cases and ManagementPistone ES, Patel MM, Brondeel K et al.2026PMID 42660550Summary
- APS Reconstructive Approach to Saddle Nose Deformity: A Diagnostic-Therapeutic Algorithm and the Preoperative Use of Hyaluronic Acid Filler for Skin Expansion in RhinoplastyBattista RA, Ferraro M, Nobile A et al.2026PMID 42324394Summary
- APS Complications of Nonsurgical Rhinoplasty with Hyaluronic Acid Injections: A Narrative ReviewCaranti A, Thomas R, Facchini F et al.2025PMID 39747417Summary
- APS 2025PMID 38977451Summary
- FPS Effect of Facial Fillers on Post-rhinoplasty edema: A Hypothesis Based on Literature ReviewMaamari SA, Vansteelant G, Appan S et al.2025PMID 39532285Summary
- FPSAM 2025PMID 39466798
- FPSAM Non-Surgical Rhinoplasty After Rhinoplasty: A Systematic Review of the Technique, Results, and ComplicationsSantamaría-Gadea A, Sevil-Serrano C, Buendía Pérez J et al.2025PMID 39230478Summary
- APS Nonsurgical Rhinoplasty: An Updated Systematic Review of Technique, Outcomes, Complications, and Its TreatmentsSong D, Wang X, Yu Z2024PMID 38862661Summary
- APS The Use of Hyaluronic Acid in Non-surgical Rhinoplasty: A Systematic Review of Complications, Clinical, and Patient-Reported OutcomesMataro I, Orlandino G, La Padula S2024PMID 37783865Summary
- APS The Use of Hyaluronic Acid in Non-surgical Rhinoplasty: A Systematic Review of Complications, Clinical, and Patient-Reported OutcomesMortada H, Korb A, Mawdsley E et al.2024PMID 37217605Summary
- PRS 2024PMID 38923925
- PRS Nonsurgical Rhinoplasty in Patients of African Descent: A Retrospective ReviewHarb A, Abdul-Razzak A2024PMID 37344935Summary
- APS Patient Satisfaction After Non-surgical Rhinoplasty Using Hyaluronic Acid: A Literature ReviewRadulesco T, De Bonnecaze G, Penicaud M et al.2021PMID 33660013Summary
- FPSAM Commentary on "Nonsurgical Rhinoplasty Using Injectable Fillers: A Safety Review of 2488 Procedures" by Rivkin: Cannula Use During Dermal Filler InjectionSulyman O, Dayan S2021PMID 33270498
- FPSAM 2021PMID 33270519Summary
- PRS The Nonsurgical Rhinoplasty: A Retrospective Review of 5000 TreatmentsBarone M, Cogliandro A, Persichetti P2021PMID 34468422
- PRS The Nonsurgical Rhinoplasty: A Retrospective Review of 5000 TreatmentsHarb A, Brewster CT2020PMID 32097303Summary
- PRS-GO Nonsurgical Correction of Surgical Rhinoplasty Complications with Hyaluronic Acid Fillers: A Retrospective Review of 2088 CasesHarb A, Abdul-Razzak A2024PMID 39247575Summary
- ASJ Secondary Liquid Rhinoplasty: Challenges, Techniques, and Long-term OutcomesValente DS, Zanella RK2026PMID 41124352Summary
- ASJ The Risk of Skin Necrosis Following Hyaluronic Acid Filler Injection in Patients With a History of Cosmetic RhinoplastyRobati RM, Moeineddin F, Almasi-Nasrabadi M2018PMID 29506052Summary
- PRS Nonsurgical Rhinoplasty: A Systematic Review of Technique, Outcomes, and ComplicationsWilliams LC, Kidwai SM, Mehta K et al.2020PMID 32590640Summary
- PRS Nonsurgical Rhinoplasty: Nasal Grid Analysis and Nasal Injecting ProtocolBertossi D, Lanaro L, Dorelan S et al.2019PMID 30531619Summary
- ASJ Nonsurgical Rhinoplasty With the Novel Hyaluronic Acid Filler VYC-25L: Results Using a Nasal Grid ApproachBertossi D, Malchiodi L, Albanese M et al.2021PMID 32628267Summary
- APS Nonsurgical Rhinoplasty: Results from a Retrospective Study of Rino-4-Puntos Technique with Hyaluronic AcidSilikovich F, Kroumpouzos G2025PMID 39060796Summary
- PRS-GO Nonsurgical Rhinoplasty: A Modified Rino-4-Puntos Technique With Hyaluronic Acid Improves the Appearance of Nasal Septal DeviationSilikovich F, Kroumpouzos G2025PMID 40416407Summary
- FPSAM Nonsurgical Rhinoplasty: Diamond Injection Technique for Nasal Tip ContouringBetti E, Catarzi L, Consorti G2024PMID 37267216Summary
- APS The Use of Cross-Linked Hyaluronic Acid in Non-surgical Rhinoplasty Using Italian TechniqueScarano A, Sbarbati A, Amuso D et al.2025PMID 38942953Summary
- APS A Cannula-Based Sequential Injection Protocol for Non-surgical Rhinoplasty in East Asian PatientsYe J, Wang X, Yi K et al.2026PMID 42443422Summary
- PRS A Safe Nonsurgical Rhinoplasty ProcedureRadulesco T, Braccini F, Kestemont P et al.2022PMID 35511074Summary
- APS Standardized Non-surgical Rhinoplasty with Hyaluronic Acid: Consistent Outcomes Across Injectors with Varying ExperienceGermani M, Roschel P, Rogerio V et al.2026PMID 41813985Summary
- APS Assessing the Long-Term Impact of Non-Surgical Rhinoplasty on Patient Satisfaction and Quality of Life: A Prospective Study Using FACE-QLombardo GAG, Melita D, Stivala A et al.2025PMID 39747421Summary
- FPS Nonsurgical Rhinoplasty: Histopathological Effects of Dermal Fillers on Nasal Cartilage in a Rabbit ModelGürlek İÖ, Gülüstan F, İnan BK et al.2026PMID 39965763Summary
- FPS Facial Fillers and Surgical Rhinoplasty: Cross-Sectional StudyVansteelant G, D'Souza A, EAFPS Filler Working Group2025PMID 39993423Summary
- FPS Surgical Management of Filler Rhinoplasty ComplicationsWong EHC, D'Souza A2025PMID 41412200Summary
- APS Revision Rhinoplasty After Non-Surgical Filler in East Asian Patients: A Safe and Effective Surgical ApproachYe J, Wang X, Zhao H et al.2025PMID 40456990Summary
- PRS Five-Principle and Five-Step Liquid RhinoplastyRohrich RJ, Novak M, Alleyne B et al.2023PMID 36728574Summary
- PRS Soft-tissue fillers in rhinoplastyKurkjian TJ, Ahmad J, Rohrich RJ2014PMID 24150121Summary
- APS Advancing the Era of Liquid Rhinoplasty: A Methodological Approach to Injection ProtocolsRadulesco T, Ebode D, Michel J2024PMID 38627333Summary
- APS The Research Trend of Non-surgical Rhinoplasty: A Bibliometric and Visualized AnalysisLiao Z, Wu Y, Cong L et al.2025PMID 40389737Summary
- APS Free Crushed Cartilage Filler Graft to Optimize Tip Aesthetics in Asian RhinoplastyChang BL, Cho WK, Jang YJ2025PMID 39322839Summary
What is still contested
- The true rate of severe complications is unknown. Reported occlusion sits at 0.27% and the vision-loss literature is 22 case reports; both come from voluntary reporting, so both are floors rather than estimates. [38862661, 42660550]
- No randomised trial exists. The reviews say so explicitly: satisfaction data come from case series, and better-designed studies are needed. [37217605, 32590640]
- Filler characteristics (viscosity, elasticity, cohesivity) are rarely reported, so the studies cannot be compared product by product even when they use the same volumes. [37783865]
- Duration is quoted as eight to fourteen months from a review of 674 patients; almost nothing on file follows patients past a year, and repeat injection intervals are not standardised. [33660013]
- What repeated filler does to nasal tissue over years is unknown in humans. The only histology on file is 90 days in rabbits, and it found chondrocyte loss, fibrosis and giant cells. [39965763]
- Whether facial filler prolongs swelling after later rhinoplasty is a hypothesis with no measurement behind it. [39532285]
- Injector experience did not change satisfaction in the one study that tested it, which says nothing about whether it changes the rate of the complications that matter. [41813985]
Written by rhinoplasty.cc from the PubMed abstracts, 2026-09-09. Not medical advice.
Related topics
Complications and management
22 of the 88 papers here also match this topic.
Outcomes, satisfaction and psychology
14 of the 88 papers here also match this topic.
Anatomy and nasal analysis
12 of the 88 papers here also match this topic.
Ethnic, Asian, Middle Eastern, African and Latino rhinoplasty
7 of the 88 papers here also match this topic.
Every paper, by year
88 papers. The 40 above are not repeated.
20266 papers · 6 above
202517 papers · 14 above
- APS Commentary on: Advancing the Era of Liquid Rhinoplasty: A Methodological Approach to Injection ProtocolsMafra NVSC, Selvaggi GPMID 39690201
- APS Response to: Commentary on: Advancing the Era of Liquid Rhinoplasty: A Methodological Approach to Injection ProtocolsRadulesco T, Ebode D, Michel JPMID 39849099
- FPSAM Nonsurgical Rhinoplasty for Nasal Dorsum Correction: Patient Selection for Predictable OutcomesBetti E, Paglianiti M, Catarzi L et al.PMID 39570692
202411 papers · 8 above
- FPSAM Commentary on: Decreased Filler Volumes with Repeat Micro-Liquid Nonsurgical Rhinoplasty SessionsCotofana SPMID 39166301
- FPSAM Decreased Filler Volumes with Repeat Micro-Liquid Nonsurgical Rhinoplasty SessionsMoubayed SP, Khoury MPMID 39591585
- FPSAM Reply to Commentary on: Decreased Filler Volumes with Repeat Micro-Liquid Nonsurgical Rhinoplasty SessionsMoubayed SP, Khoury MPMID 39172533
20232 papers · 1 above
- CPS Liquid RhinoplastySaad N, Stallworth CLPMID 37169410Summary
202211 papers · 1 above
- APS Surgical Rhinoplasty After Hyaluronic Acid Injection: What Are the Implications? Our ExperienceGuastafierro A, Rosso S, Avvedimento S et al.PMID 34109452Full text
- CPS Nonsurgical RhinoplastyRohrich R, Alleyne B, Novak M et al.PMID 34782136Summary
- FPS Nonsurgical Rhinoplasty: Long-Term Follow-Up of High G' HA Nasal InjectionsBertossi D, Magagnotto N, Chirumbolo S et al.PMID 35158387Summary
- FPSAM PMID 34448622
- FPS Clin Effect of Surgical versus Nonsurgical Rhinoplasty on Perception of the Patient: An Eye-Tracking-Based InvestigationKassir R, Kassir S, Hofmann L et al.PMID 35501055Summary
- FPS Clin Liquid RhinoplastySaad N, Stallworth CLPMID 35934437Summary
- FPS Clin The Deep Columellar Approach for Liquid Rhinoplasty - A Case Series of 511 Procedures over 16 yearsMagacho-Vieira FN, Alfertshofer MG, Cotofana SPMID 35501057Summary
- FPS Clin Ultrasound Anatomy of the Dorsal Nasal Artery as it Relates to Liquid Rhinoplasty ProceduresAlfertshofer MG, Frank K, Moellhoff N et al.PMID 35501050Summary
- PRS-GO Hybrid Nasal Filler: Combining Agarose Gel and Hyaluronic Acid for Nonsurgical RhinoplastyBuhsem O, Kirazoglu APMID 35402124Summary
- PRS-GO PMID 35999875Summary
202111 papers · 5 above
- APS Invited Discussion on: "Management of Patients Seeking Surgical Rhinoplasty with Previous Nasal Injections of Hyaluronic Acid"Gubisch W, Hacker SPMID 33782723
- APS Management of Patients Seeking Surgical Rhinoplasty with Previous Nasal Injections of Hyaluronic AcidRamos HHA, Freire L, Cavallieri F et al.PMID 33616714Summary
- APS Non-Surgical Rhinoplasty: The Ascending Technique and a 14-Year Retrospective Study of 2130 CasesKassir R, Venkataram A, Malek A et al.PMID 33216177Summary
- PRS The "3P" Maneuver: A Simple Technique to Improve Vascular Safety in Nonsurgical RhinoplastySegreto F, Marangi GF, Caldaria E et al.PMID 33027204
- PRS The Nonsurgical Rhinoplasty: A Retrospective Review of 5000 TreatmentsRadulesco T, Sowerby LJ, Hopkins C et al.PMID 33961592
- PRS The Nonsurgical Rhinoplasty: A Retrospective Review of 5000 TreatmentsYordanov YP, Shef APMID 33760777
20207 papers · 2 above
- APS PMID 32072215
- APS Non-surgical Rhinoplasty with Hyaluronic acid Fillers: Predictable Results Using Software for the Evaluation of Nasal AnglesSantorelli A, Marlino SPMID 31832736Summary
- APS Psychological Analysis of Non-surgical RhinoplastyDi Rosa L, Cerulli G, De Pasquale APMID 31768580Summary
- PRS-GO Entrapment Neuropathy Causing Persistent Headache Symptoms after Nonsurgical RhinoplastyBenjamin M, McGregor A, Yousif S et al.PMID 33425572Summary
- PRS-GO Safety in the Use of Fillers in Nasal Augmentation-the Liquid RhinoplastyRohrich RJ, Agrawal N, Avashia Y et al.PMID 32983752Full text
20198 papers · 1 above
- APS A Safer Non-surgical Filler Augmentation Rhinoplasty Based on the Anatomy of the NoseJung GS, Chu SG, Lee JW et al.PMID 30560283Summary
- APS Supercooled Liquid Serum Physiologic Solution Instantly Crystallized on the Nurse Table Used for Cooling of Periorbital Region During RhinoplastyÇerçi Özkan A, Güven E, Toktaş B et al.PMID 30535556Summary
- FPS Effect of Injectable Platelet-Rich Fibrin on Diced Cartilage's Viability in RhinoplastyGode S, Ozturk A, Berber V et al.PMID 31307095Summary
- FPS PMID 30759462
- FPS Clin Advanced Techniques in Nonsurgical RhinoplastyMehta U, Fridirici ZPMID 31280849Summary
- PRS PMID 31348378
- PRS-GO Nonsurgical Rhinoplasty: A Graft-based TechniqueSegreto F, Marangi GF, Cerbone V et al.PMID 31624669Summary
20185 papers · 1 above
- ASJ PMID 29788065
- ASJ Filler Rhinoplasty: Evidence, Outcomes, and ComplicationsSingh P, Vijayan R, Nikkhah DPMID 30265278
- FPS PMID 29857337Summary
- FPS Clin PMID 30005788Summary
20172 papers
- APS Delayed-Onset Edematous Foreign Body Granulomas 40 Years After Augmentation Rhinoplasty by Silicone Implant Combined with Liquid Silicone InjectionHu HC, Fang HW, Chiu YHPMID 28130558Summary
- JAMA FPS Nonsurgical RhinoplastyKontis TCPMID 28492936
20163 papers
- CPS PMID 26616716Summary
- FPS Nonsurgical RhinoplastyJohnson ON 3rd, Kontis TCPMID 27680521Summary
- PRS-GO Serious Vascular Complications after Nonsurgical Rhinoplasty: A Case ReportChen Q, Liu Y, Fan DPMID 27200245Summary
20151 papers
- FPS PMID 26126227Summary
20141 papers · 1 above
20131 papers
- FPS Clin PMID 23731585Summary
20122 papers
- APS Structured nonsurgical Asian rhinoplastyKim P, Ahn JTPMID 22350307Summary
- PRS Multiplane hyaluronic acid rhinoplastyXue K, Chiang CA, Liu K et al.PMID 22286467